Psychometric evaluation of the leg activity measure (LegA) for outcome measurement in people with brain injury and spasticity

References

• van Kuijk A, Hendricks H, Pasman J, et al. Are neuroradiological or neurophysiological characteristics associated with upper-extremity hypertonia in severe ischaemia in supratentorial stroke? J Rehabil Med. 2007;39:38–42.
   PubMed Web of Science ®Google Scholar
• Watkins CL, Leathley MJ, Gregson JM, et al. Prevalence of spasticity post stroke. Clin Rehabil. 2002;16:515–522.
   PubMed Web of Science ®Google Scholar
• Urban P, Wolf T, Uebele M, et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41:2016–2020.
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapist Interested in Neurology. Spasticity in adults: management using botulinum toxin - National Guidelines. London: Royal College of Physicians, Clinical Effectiveness and Evaluation Unit; 2009.
   Google Scholar
• Sheean GL. Botulinum treatment of spasticity: why is it difficult to show a functional benefit? Trauma Rehab. 2001;14:771–776.
   Google Scholar
• Ashford S, Brown S, Turner-Stokes L. Systematic review of patient reported outcome measures (PROMS) for functional performance in the lower limb. J Rehabil Med. 2015;47:9–17.
   PubMed Web of Science ®Google Scholar
• WHO. International classification of functioning, disability and health. Geneva: World Health Organisation; 2002.
   Google Scholar
• Ashford S, Jackson D, Mahaffey P, et al. Conceptualisation and development of the Leg Activity Measure (LegA) for patient and carer reported assessment of activity (function) in the paretic leg in people with acquired brain injury. Physiother Res Int. 2017;22. DOI:10.1002/pri.1660
   Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–549.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. COSMIN checklist manual. Amsterdam, The Netherlands: VU University Medical Center; 2012.
   Google Scholar
• Sim J, Wright CC. The Kappa statistic in reliability studies: Use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–268.
   PubMed Web of Science ®Google Scholar
• Roorda LD, Green JR, Houwink A, et al. The Rivermead Mobility Index allows valid comparisons between subgroups of patients undergoing rehabilitation after stroke who differ with respect to age, sex, or side of lesion. Arch Phys Med Rehabil. 2012;93:1086–1090.
   PubMed Web of Science ®Google Scholar
• Leung YY, Png ME, Conaghan P, et al. A systematic literature review on the application of Rasch analysis in musculoskeletal disease – a special interest group report of OMERACT 11. J Rheumatol. 2014;41:159–164.
   PubMed Web of Science ®Google Scholar
• Collen FM, Wade DT, Robb GF, et al. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Studies. 1991;13:50–54.
   PubMedGoogle Scholar
• Hsieh CL, Hsueh IP, Mao HF. Validity and responsiveness of the rivermead mobility index in stroke patients. Scand J Rehabil Med. 2000;32:140–142.
   PubMedGoogle Scholar
• Roorda LD, Green JR, Houwink A, et al. Item hierarchy-based analysis of the Rivermead Mobility Index resulted in improved interpretation and enabled faster scoring in patients undergoing rehabilitation after stroke. Arch Phys Med Rehabil. 2012;93:1091–1096.
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Brashear A, Zafonte R, Corcoran M, et al. Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb post-stroke spasticity. Arch Phy Med Rehab. 2002;83:1349–1354.
   PubMed Web of Science ®Google Scholar
• Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press; 1992.
   Google Scholar
• Ashford S, Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiother Res Int. 2006;11:24–34.
   PubMedGoogle Scholar
• Turner-Stokes L. Goal attainment scaling (GAS) a practical guide. Clin Rehabil. 2009;23:362–370.
   PubMed Web of Science ®Google Scholar
• McCrory P, Turner-Stokes L, Baguley I, et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med. 2009;41:536–544.
   PubMed Web of Science ®Google Scholar
• Shaw L, Rodgers H, Price C, et al. BoTULS: a multicentre randomised-controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin A. Health Tech Assessm. 2010;14:1–113.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Bmj. 1995;310:170.
   PubMed Web of Science ®Google Scholar
• Smith EVJ. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas. 2002;3:205–231.
   PubMedGoogle Scholar
• Landis J, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
   PubMed Web of Science ®Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, et al. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatr. 2000;69:217–221.
   PubMed Web of Science ®Google Scholar
• Ashford S, Slade M, Nair A, et al. Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatment. Int J Ther Rehab. 2014;21:10–17.
   Google Scholar
• Ashford S, Slade M, Turner-Stokes L. Conceptualisation and development of the Arm Activity measure (ArmA) for assessment of activity in the hemiparetic arm. Disabil Rehabil. 2013;35:1513–1518.
   PubMed Web of Science ®Google Scholar
• Ashford S, Turner-Stokes L, Siegert R, et al. Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm. Clin Rehabil. 2013;27:728–740.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Baguley I, De Graaff S, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med. 2010;42:81–89.
   PubMed Web of Science ®Google Scholar